Table 1.
Patient demographics, admission, and treatment characteristics nasal cannula (NC); high‐flow nasal cannula (HFNC), continuous positive airway pressure (CPAP)
| Patient characteristics, n = 7 | |
|---|---|
| Median age | 17 y (15‐18 y) |
| Race | 100% Caucasian |
| Sex | |
| Male | 4 (57%) |
| Female | 3 (43%) |
| Confirmed EVALI cases | 4 (57%) |
| Probable EVALI cases | 3 (43%) |
| Median length of stay | 6.5 d (1‐10 d) |
| Median length of PICU admission | 5 d (3‐7 d) |
| Patients requiring respiratory support | 5 (71%) |
| Median length of respiratory support | 8 d (5‐10 d) |
| Type of respiratory support | |
| NC | 5 (71%) |
| HFNC | 4 (57%) |
| CPAP | 1 (14%) |
| Patients treated with systemic steroids | 3 (42%) |
| Patients presenting with GI symptoms | 4 (57%) |
| Median CRP level | 34.9 mg/dL (0.2‐42.9 mg/dL) |
| Median postdischarge % predicted FEV1 | 105% |
Abbreviations: CRP, C‐reactive protein; EVALI, e‐cigarette or vaping product use‐associated lung injury; FEV1, forced expiratory volume in 1 second; GI, gastrointestinal; PICU, pediatric intensive care unit.